Literature DB >> 26366535

Genome-wide Association Study of Postburn Scarring Identifies a Novel Protective Variant.

Ravi F Sood1, Anne M Hocking, Lara A Muffley, Maricar Ga, Shari Honari, Alexander P Reiner, Nicole S Gibran.   

Abstract

OBJECTIVE: To identify genetic variants associated with the severity of postburn hypertrophic scarring (HTS) using a genome-wide approach.
BACKGROUND: Risk of severe postburn HTS is known to depend on race, but the genetic determinants of HTS are unknown.
METHODS: We conducted a genome-wide association study (GWAS) in a prospective cohort of adults admitted with deep-partial-thickness burns from 2007 through 2014. Scar severity was assessed over time using the Vancouver Scar Scale (VSS), and DNA was genotyped with a >500,000-marker array. We performed association testing of single-nucleotide polymorphisms (SNPs) with minor allele frequency (MAF) >0.01 using linear regression of VSS height score on genotype adjusted for patient and injury characteristics as well as population genetic structure. Array-wide significance was based on Bonferroni correction for multiple testing.
RESULTS: Of 538 patients (median age 40 years, median burn size 6.0% of body surface area), 71% were men and 76% were White. The mean VSS height score was 1.2 (range: 0-3). Of 289,639 SNPs tested, a variant in the CUB and Sushi multiple domains 1 (CSMD1) gene (rs11136645; MAF = 0.49), was significantly associated with decreased scar height (regression coefficient = -0.23, P = 7.9 × 10).
CONCLUSIONS: In the first published GWAS of HTS, we report that a common intronic variant in the CSMD1 gene is associated with reduced severity of postburn HTS. If this association is confirmed in an independent cohort, investigating the potential role of CSMD1 in wound healing may elucidate HTS pathophysiology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26366535     DOI: 10.1097/SLA.0000000000001439

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  9 in total

Review 1.  Scar management in burn injuries using drug delivery and molecular signaling: Current treatments and future directions.

Authors:  Saeid Amini-Nik; Yusef Yousuf; Marc G Jeschke
Journal:  Adv Drug Deliv Rev       Date:  2017-07-27       Impact factor: 15.470

2.  The Presence of Scarring and Associated Morbidity in the Burn Model System National Database.

Authors:  Jeremy Goverman; Waverley He; Geoffrey Martello; Ann Whalen; Edward Bittner; John Schulz; Nicole Gibran; David Herndon; Oscar Suman; Karen Kowalske; Walter J Meyer; Colleen Ryan; Jeffrey Schneider
Journal:  Ann Plast Surg       Date:  2019-03       Impact factor: 1.763

3.  Microplasma radiofrequency technology combined with triamcinolone improved the therapeutic effect on Chinese patients with hypertrophic scar and reduced the risk of tissue atrophy.

Authors:  Shui Yu; Hengjin Li
Journal:  Ther Clin Risk Manag       Date:  2016-05-10       Impact factor: 2.423

4.  Missense Variant in MAPK Inactivator PTPN5 Is Associated with Decreased Severity of Post-Burn Hypertrophic Scarring.

Authors:  Ravi F Sood; Saman Arbabi; Shari Honari; Nicole S Gibran
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

Review 5.  Mesenchymal stem cell therapy in hypertrophic and keloid scars.

Authors:  Christine Bojanic; Kendrick To; Adam Hatoum; Jessie Shea; K T Matthew Seah; Wasim Khan; Charles M Malata
Journal:  Cell Tissue Res       Date:  2021-01-02       Impact factor: 5.249

6.  Inhibition of CUB and sushi multiple domains 1 (CSMD1) expression by miRNA-190a-3p enhances hypertrophic scar-derived fibroblast migration in vitro.

Authors:  Shuchen Gu; Xin Huang; Xiangwen Xu; Yunhan Liu; Yimin Khoong; Zewei Zhang; Haizhou Li; Yashan Gao; Tao Zan
Journal:  BMC Genomics       Date:  2021-08-12       Impact factor: 3.969

Review 7.  The Emerging Therapeutic Targets for Scar Management: Genetic and Epigenetic Landscapes.

Authors:  Sara Amjadian; Sharif Moradi; Parvaneh Mohammadi
Journal:  Skin Pharmacol Physiol       Date:  2022-06-13       Impact factor: 3.014

Review 8.  Genomics of Human Fibrotic Diseases: Disordered Wound Healing Response.

Authors:  Rivka C Stone; Vivien Chen; Jamie Burgess; Sukhmani Pannu; Marjana Tomic-Canic
Journal:  Int J Mol Sci       Date:  2020-11-14       Impact factor: 5.923

Review 9.  A Scoping Review of the Methodology Used in Studies of Genetic Influences on the Development of Keloid or Hypertrophic Scarring in Adults and Children After Acute Wounding.

Authors:  Philippa Davies; Leila Cuttle; Amber Young
Journal:  Adv Wound Care (New Rochelle)       Date:  2021-07-14       Impact factor: 4.730

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.